Results 101 to 110 of about 5,352 (210)

DEVELOPMENT AND VALIDATION OF A NEW RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF EMTRICITABINE TENOFOVIR COBICISTAT ELVITEGRAVIR AND ITS COMPARISION WITH A REPORTED METHOD

, 2017
A new stability indicating RP HPLC method has been developed and validated for simultaneous estimation of Emtricitabine, Tenofovir, Cobicistat and Elvitegravir in bulk and dosage forms. The method involves separation on Kromasil C18 column (250mm x 4.6mm
Mangamma.Kuna*, Gowri Sankar Dannana and S.V.U.M.Prasad
core   +1 more source

Darunavir/Cobicistat [PDF]

, 2020
openaire   +1 more source

Atazanavir/Cobicistat [PDF]

, 2020
openaire   +1 more source

Profile of once-daily darunavir/cobicistat fixed-dose combination for the treatment of HIV/AIDS

Altres ajuts: AC has received honoraria, speakers' fees and/or funds for research from Bristol-Myers Squibb, Abbvie, Gilead Sciences, Janssen-Cilag, MSD, and ViiV Healthcare. JN has received honoraria, speakers' fees and/or funds for research from Abbvie,
Curran, Adrian, Navarro, Jordi, Universitat Autònoma de Barcelona   +2 more
core  

Delayed Multisystem Deterioration Following Large-Volume Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Overdose. [PDF]

Cureus
Javed HM, Cuello S, Omer M, Buryk Y.
europepmc   +1 more source

Therapeutic drug monitoring uncovering incorrect antiretroviral drug intake in a patient with swallowing difficulties. [PDF]

IDCases
Carrozzo G, Cattaneo D, Giacomelli A, Gori A, Ridolfo AL, Gervasoni C, Cossu MV.   +6 more
europepmc   +1 more source

Need for Medication Review and Deprescribing in People Living with HIV: A Longitudinal Observational Study. [PDF]

Pharmaceuticals (Basel)
De Bellis E, Donnarumma D, Pagano A, Mazza I, Charlier B, Madonia S, Masullo A, Onofrio M, Fortunato V, Spera AM, Campana F, Franci G, Salzano F, Corbi G, Filippelli A, Pagliano P, Conti V.   +16 more
europepmc   +1 more source

Comparative and Subtractive Genomics Analysis of Multidrug-Resistant <i>Klebsiella pneumoniae</i> Strains for Novel Target Identification and Drug Repurposing Strategies. [PDF]

Int J Microbiol
Bora M, Paul P, Rajkhowa S, Sonar H, Gohain BB, Zaki MEA, Prabhu D.   +6 more
europepmc   +1 more source

Kinetic Characterization of elvitegravir (EVG) in the presence and absence of cobicistat (COBI) and/or ethanol (EtOH)

, 2016
Kinetic Characterization of elvitegravir (EVG) in the presence and absence of cobicistat (COBI) and/or ethanol (EtOH)
Mohammad A. Rahman (1806823), Chetan Rathi (1806826), Weihua Li (144468), Santosh Kumar (106550), Bernd Meibohm (110267), Junhao Li (844050), Narasimha M. Midde (309014)   +6 more
core  

Primary Cardiovascular Prevention in People Living With HIV: Rethinking Statin Therapy in the Post-REPRIEVE Era. [PDF]

Curr HIV/AIDS Rep
Fusco P, De Maria F, Tassone B, Russo A.
europepmc   +1 more source